eClinicalソリューションの世界市場規模調査＆予測、製品別、提供形態別、展開形態別、エンドユース別、地域別分析、2023-2030年

eClinicalソリューションの世界市場は、2022年に約80億6,000万米ドルと評価され、予測期間2023-2030年には14.1％以上の健全な成長率で成長すると予測されています。

eClinicalソリューションは、電子データ収集および臨床データ管理システム、臨床試験管理システム、無作為化および治験薬供給管理など、技術主導のさまざまなツールを包含します。これらのソリューションは、臨床試験データの合理的かつ高度な管理において重要な役割を果たします。これらのソリューションは、臨床試験中に生成されるデータを効果的に整理・統合することで、臨床試験ポートフォリオの計画、監督、モニタリングのための包括的なツール群を提供します。これらのソリューションは、連絡先管理、カレンダー、モニタリング、文書管理を統合することで、良好な臨床研究成果の達成と、申請におけるコンプライアンスの確保に貢献します。eClinicalソリューションは、効率的なデータ入力、保存、規制を促進し、データの完全性と信頼性の認証も保証します。eClinicalソリューションの導入は、医薬品開発のタイムラインを迅速化し、臨床調査方法における全体的な患者体験を向上させることに貢献します。大手製薬企業やバイオ製薬企業による臨床試験研究の外部化の増加、eClinicalソリューションの利点の増大、パイプラインにある強力な製品群の存在が、世界全体での市場成長の主な促進要因となっています。

加えて、臨床試験におけるソフトウェアソリューションの導入拡大が、推定期間中の市場需要を後押しする最も顕著な要因となっています。複数の施設や地域が関与する臨床試験の世界化により、一元化され標準化されたデータ管理システムが必要とされています。Statistaによると、2019年には世界中で約32万5,776件の臨床試験が登録され、これは継続的に増加しており、2022年3月時点で40万9,300件に達しています。eクリニカルソリューションは、異なる場所間でのシームレスなコラボレーションとデータ共有を可能にし、これが世界の市場需要を促進しています。さらに、臨床試験プロセスのCROへのアウトソーシングの増加や、手作業によるデータ解釈からリアルタイムのデータ分析への段階的な移行は、予測期間中に様々な有利な機会をもたらします。しかし、熟練した研究専門家の不足と認知度の低さが、2023-2030年の予測期間を通じて市場の成長を妨げています。

eClinicalソリューションの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東＆アフリカです。北米は、対象人口の増加と糖尿病や心疾患などのライフスタイル関連疾患の有病率の増加により、2022年の市場を独占しました。同市場は、eクリニカル・ソリューション・プロバイダーによる新製品のイントロダクションと、同地域内での政府助成金の増加によってさらに推進されています。さらに、大手業界プレイヤーの存在と高度なインフラへのアクセスが、この地域の市場拡大に大きく貢献すると予想されます。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。アンメット・メディカル・ニーズが大きく、がん、心血管疾患、感染症などの慢性疾患の罹患率が上昇していることが、同地域全体の市場需要を大きく押し上げています。中国、インド、韓国、日本などは、患者数が多く、コスト面でも有利であるため、臨床試験のアウトソーシングが増加傾向にあります。このようなアウトソーシングは、これらの地域におけるeClinicalソリューションの採用を大幅に促進しています。APAC市場の成長をさらに後押ししているのは、新興経済国としての地位であり、研究・創薬に向けられた政府資金が当面の市場拡大を後押しすると期待されています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 eClinicalソリューションの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 eClinicalソリューションの世界市場力学

• eClinicalソリューション市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 強力な製品群の存在感の高まり
    • 臨床試験におけるソフトウェアソリューションの増加
  • 市場の課題
    • 熟練した研究専門家の不足
    • 認知度の不足
  • 市場機会
    • CROへの臨床試験プロセスのアウトソーシングの増加
    • 手動データ解釈からリアルタイムデータ解析への段階的シフト

第4章 世界のeClinicalソリューション市場：産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 eClinicalソリューションの世界市場：製品別

• 市場スナップショット
• eClinicalソリューションの世界市場：製品別 実績 - ポテンシャル分析
• eClinicalソリューションの世界市場：製品別 推定・予測 2020-2030年
• eClinicalソリューション市場、サブセグメント別分析
  • 電子データ収集（EDC）および臨床データ管理システム（CDMS）
  • 臨床試験管理システム（CTMS）
  • 臨床分析プラットフォーム
  • 無作為化および治験薬供給管理（RTSM）
  • 臨床データ統合プラットフォーム
  • 電子臨床アウトカム評価（eCOA）
  • 安全性ソリューション
  • 電子治験マスターファイル（eTMF）

第6章 eClinicalソリューションの世界市場：提供形態別

• 市場スナップショット
• eClinicalソリューションの世界市場：提供形態別 実績 - ポテンシャル分析
• eClinicalソリューションの世界市場：提供形態別 推定・予測2020～2030年
• eClinicalソリューション市場、サブセグメント分析
  • ウェブおよびクラウドベース
  • オンプレミス

第7章 eClinicalソリューションの世界市場：展開形態別

• 市場スナップショット
• eClinicalソリューションの世界市場：展開形態別 実績-ポテンシャル分析
• eClinicalソリューションの世界市場：展開形態別 推定・予測2020～2030年
• eClinicalソリューション市場、サブセグメント分析
  • フェーズi
  • フェーズII
  • フェーズIII
  • フェーズIV

第8章 eClinicalソリューション市場、エンドユーザー別

• 市場スナップショット
• eClinicalソリューションの世界市場：エンドユース別 実績 - ポテンシャル分析
• eClinicalソリューションの世界市場、エンドユース別 推定・予測2020-2030
• eClinicalソリューション市場、サブセグメント分析
  • 病院/ヘルスケアプロバイダー
  • CRO
  • 学術機関
  • 製薬・バイオテクノロジー企業
  • 医療機器メーカー

第9章 eClinicalソリューションの世界市場：地域分析

• 主要国
• 主な新興国
• eClinicalソリューション市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品の推定・予測、2020-2030年
    • デリバリーモードの推定・予測、2020-2030年
    • 開発フェーズの推定・予測、2020～2030年
    • 最終用途別の推定・予測、2020-2030年
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Datatrak International, Inc.
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • OracleCorporation
  • Parexel International Corporation
  • Dassault Systemes
  • Bioclinica
  • CRF Health
  • ERT Clinical
  • eClinicalWorks
  • IBM Watson Health
  • Anju Life Sciences Software

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global EClinical Solutions Market, report scope
• TABLE 2. Global EClinical Solutions Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global EClinical Solutions Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 4. Global EClinical Solutions Market estimates & forecasts by Delivery Mode 2020-2030 (USD Billion)
• TABLE 5. Global EClinical Solutions Market estimates & forecasts by Development Phases 2020-2030 (USD Billion)
• TABLE 6. Global EClinical Solutions Market estimates & forecasts by End-use 2020-2030 (USD Billion)
• TABLE 7. Global EClinical Solutions Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global EClinical Solutions Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global EClinical Solutions Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global EClinical Solutions Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global EClinical Solutions Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global EClinical Solutions Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global EClinical Solutions Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global EClinical Solutions Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global EClinical Solutions Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. Global EClinical Solutions Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 18. U.S. EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. U.S. EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 21. Canada EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. Canada EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 24. UK EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. UK EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 27. Germany EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. Germany EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 30. France EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. France EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 33. Italy EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Italy EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 36. Spain EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. Spain EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 39. RoE EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. RoE EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 42. China EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. China EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 45. India EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. India EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 48. Japan EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. Japan EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 51. South Korea EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. South Korea EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 54. Australia EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. Australia EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 57. RoAPAC EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. RoAPAC EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 60. Brazil EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Brazil EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 63. Mexico EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. Mexico EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 66. RoLA EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. RoLA EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. Saudi Arabia EClinical Solutions Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 69. South Africa EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. RoMEA EClinical Solutions Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global EClinical Solutions Market
• TABLE 72. List of primary sources, used in the study of global EClinical Solutions Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable.

LIST OF FIGURES

• FIG 1. Global EClinical Solutions Market, research methodology
• FIG 2. Global EClinical Solutions Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global EClinical Solutions Market, key trends 2022
• FIG 5. Global EClinical Solutions Market, growth prospects 2023-2030
• FIG 6. Global EClinical Solutions Market, porters 5 force model
• FIG 7. Global EClinical Solutions Market, pest analysis
• FIG 8. Global EClinical Solutions Market, value chain analysis
• FIG 9. Global EClinical Solutions Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global EClinical Solutions Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global EClinical Solutions Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global EClinical Solutions Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global EClinical Solutions Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global EClinical Solutions Market, regional snapshot 2020 & 2030
• FIG 15. North America EClinical Solutions Market 2020 & 2030 (USD Billion)
• FIG 16. Europe EClinical Solutions Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific EClinical Solutions Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America EClinical Solutions Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa EClinical Solutions Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable.

Global EClinical Solutions Market is valued at approximately USD 8.06 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.1% over the forecast period 2023-2030. EClinical Solutions encompass a range of technology-driven tools, including electronic data capture and clinical data management systems, clinical trial management systems, and randomization and trial supply management. These solutions play a crucial role in the streamlined and enhanced management of clinical trial data. They provide a comprehensive set of tools for planning, overseeing, and monitoring clinical study portfolios by effectively organizing and integrating data generated during clinical trials. These solutions contribute to achieving favorable clinical research outcomes and ensuring compliance in submissions through the integration of contact management, calendars, monitoring, and document management. They facilitate efficient data entry, storage, and regulation, while also ensuring the authentication of data integrity and reliability. The implementation of eClinical Solutions contributes to expediting drug development timelines and enhancing the overall patient experience in the clinical research process. The rising externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies, the growing advantages of eClinical solutions, coupled with the presence of a strong range of products in the pipeline are the key driving factors for market growth across the globe.

In addition, the growing incorporation of software solutions in clinical trials is the most prominent factor that is propelling the market demand over the estimated period. The globalization of clinical trials, involving multiple sites and geographies, requires centralized and standardized data management systems. According to Statista, in 2019, there were approximately 325,776 clinical studies were registered worldwide, which is continuously rising and reaching 409,300 as of March 2022. eClinical Solutions enables seamless collaboration and data sharing across different locations, which is fueling the market demand globally. Moreover, the growing outsourcing of clinical trial processes to CROs, as well as the gradual shift from manual data interpretation to real-time data analysis presents various lucrative opportunities over the forecast years. However, the scarcity of skilled research professionals and lack of recognition are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global EClinical Solutions Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing target population and an increase in the prevalence of lifestyle-related conditions such as diabetes and cardiac disorders. The market is further propelled by the introduction of new products from eClinical solution providers and rising government grants within the region. Additionally, the presence of major industry players and access to advanced infrastructure are anticipated to contribute significantly to the regional market's expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Substantial unmet medical needs and a rising incidence of chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are significantly propelling the market demand across the region. A growing trend involves outsourcing a considerable number of clinical trials to countries such as China, India, Korea, and Japan, given their substantial patient populations and cost advantages. This outsourcing practice has significantly fueled the adoption of eClinical solutions in these regions. The APAC market's growth is further propelled by its status as an emerging economy, with government funding directed toward research and drug discovery, expected to bolster its expansion in the foreseeable future.

Major market players included in this report are:

• Datatrak International, Inc.
• OracleCorporation
• Parexel International Corporation
• Dassault Systemes
• Bioclinica
• CRF Health
• ERT Clinical
• eClinicalWorks
• IBM Watson Health
• Anju Life Sciences Software

Recent Developments in the Market:

• In June 2023, Syneos Health entered a collaboration with uMotif Limited, leveraging an advanced digital platform that integrates powerful Electronic Clinical Outcome Assessment (eCOA) and Electronic Patient-reported Outcomes (ePRO) capabilities. The objective of this partnership is to expedite clinical trials, enhancing the efficiency of delivering innovative medications to patients.
• In May 2023, eClinical Solutions LLC. unveils the development of its Artificial Intelligence (AI) and Machine Learning (ML) capabilities within the Elluminate IQ offering. This advancement enables data management teams to conduct data reviews with increased efficiency and scalability, offering ML and AI features.

Global EClinical Solutions Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Delivery Mode, Development Phases, End-use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
• Clinical Trial Management Systems (CTMS)
• Clinical Analytics Platforms
• Randomization and Trial Supply Management (RTSM)
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment (eCOA)
• Safety Solutions
• Electronic Trial Master File (eTMF)

By Delivery Mode:

• Web and Cloud based
• On- Premise

By Development Phases:

• Phase I
• Phase II
• Phase III
• Phase IV

By End-use:

• Hospitals/Healthcare providers
• CROs
• Academic Institutes
• Pharma & Biotech Organizations
• Medical Device Manufacturers

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. EClinical Solutions Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. EClinical Solutions Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. EClinical Solutions Market, by Delivery Mode, 2020-2030 (USD Billion)
  • 1.2.4. EClinical Solutions Market, by Development Phases, 2020-2030 (USD Billion)
  • 1.2.5. EClinical Solutions Market, by End-use, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global EClinical Solutions Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global EClinical Solutions Market Dynamics

• 3.1. EClinical Solutions Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing presence of strong range of products
    • 3.1.1.2. Rising incorporation of software solutions in clinical trials
  • 3.1.2. Market Challenges
    • 3.1.2.1. Scarcity of skilled research professionals
    • 3.1.2.2. Lack of recognition
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing outsourcing of clinical trial processes to CROs
    • 3.1.3.2. Gradual shift from manual data interpretation to real-time data analysis

Chapter 4. Global EClinical Solutions Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global EClinical Solutions Market, by Product

• 5.1. Market Snapshot
• 5.2. Global EClinical Solutions Market by Product, Performance - Potential Analysis
• 5.3. Global EClinical Solutions Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. EClinical Solutions Market, Sub Segment Analysis
  • 5.4.1. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • 5.4.2. Clinical Trial Management Systems (CTMS)
  • 5.4.3. Clinical Analytics Platforms
  • 5.4.4. Randomization and Trial Supply Management (RTSM)
  • 5.4.5. Clinical Data Integration Platforms
  • 5.4.6. Electronic Clinical Outcome Assessment (eCOA)
  • 5.4.7. Safety Solutions
  • 5.4.8. Electronic Trial Master File (eTMF)

Chapter 6. Global EClinical Solutions Market, by Delivery Mode

• 6.1. Market Snapshot
• 6.2. Global EClinical Solutions Market by Delivery Mode, Performance - Potential Analysis
• 6.3. Global EClinical Solutions Market Estimates & Forecasts by Delivery Mode 2020-2030 (USD Billion)
• 6.4. EClinical Solutions Market, Sub Segment Analysis
  • 6.4.1. Web and Cloud based
  • 6.4.2. On- Premise

Chapter 7. Global EClinical Solutions Market, by Development Phases

• 7.1. Market Snapshot
• 7.2. Global EClinical Solutions Market by Development Phases, Performance - Potential Analysis
• 7.3. Global EClinical Solutions Market Estimates & Forecasts by Development Phases 2020-2030 (USD Billion)
• 7.4. EClinical Solutions Market, Sub Segment Analysis
  • 7.4.1. Phase I
  • 7.4.2. Phase II
  • 7.4.3. Phase III
  • 7.4.4. Phase IV

Chapter 8. EClinical Solutions Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global EClinical Solutions Market by End-use, Performance - Potential Analysis
• 8.3. Global EClinical Solutions Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
• 8.4. EClinical Solutions Market, Sub Segment Analysis
  • 8.4.1. Hospitals/Healthcare providers
  • 8.4.2. CROs
  • 8.4.3. Academic Institutes
  • 8.4.4. Pharma & Biotech Organizations
  • 8.4.5. Medical Device Manufacturers

Chapter 9. Global EClinical Solutions Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. EClinical Solutions Market, Regional Market Snapshot
• 9.4. North America EClinical Solutions Market
  • 9.4.1. U.S. EClinical Solutions Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Delivery Mode breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Development Phases breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada EClinical Solutions Market
• 9.5. Europe EClinical Solutions Market Snapshot
  • 9.5.1. U.K. EClinical Solutions Market
  • 9.5.2. Germany EClinical Solutions Market
  • 9.5.3. France EClinical Solutions Market
  • 9.5.4. Spain EClinical Solutions Market
  • 9.5.5. Italy EClinical Solutions Market
  • 9.5.6. Rest of Europe EClinical Solutions Market
• 9.6. Asia-Pacific EClinical Solutions Market Snapshot
  • 9.6.1. China EClinical Solutions Market
  • 9.6.2. India EClinical Solutions Market
  • 9.6.3. Japan EClinical Solutions Market
  • 9.6.4. Australia EClinical Solutions Market
  • 9.6.5. South Korea EClinical Solutions Market
  • 9.6.6. Rest of Asia Pacific EClinical Solutions Market
• 9.7. Latin America EClinical Solutions Market Snapshot
  • 9.7.1. Brazil EClinical Solutions Market
  • 9.7.2. Mexico EClinical Solutions Market
• 9.8. Middle East & Africa EClinical Solutions Market
  • 9.8.1. Saudi Arabia EClinical Solutions Market
  • 9.8.2. South Africa EClinical Solutions Market
  • 9.8.3. Rest of Middle East & Africa EClinical Solutions Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Datatrak International, Inc.
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. OracleCorporation
  • 10.3.3. Parexel International Corporation
  • 10.3.4. Dassault Systemes
  • 10.3.5. Bioclinica
  • 10.3.6. CRF Health
  • 10.3.7. ERT Clinical
  • 10.3.8. eClinicalWorks
  • 10.3.9. IBM Watson Health
  • 10.3.10. Anju Life Sciences Software

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption